characteristics.text: SAMN33764697
characteristics.characteristic: External Id
characteristics.text: Grimsholm, Pathophysiology and Allergy Research, Medical University of Vienna
characteristics.characteristic: INSDC center name
characteristics.text: 2023-04-05T00:00:00Z
characteristics.characteristic: INSDC first public
characteristics.text: 2023-04-05T19:36:07.133Z
characteristics.characteristic: INSDC last update
characteristics.text: SRS17049169
characteristics.characteristic: INSDC secondary accession
characteristics.text: live
characteristics.characteristic: INSDC status
characteristics.text: Generic
characteristics.characteristic: NCBI submission model
characteristics.text: Generic.1.0
characteristics.characteristic: NCBI submission package
characteristics.text: SRS17049169
characteristics.characteristic: SRA accession
characteristics.text: Naive B cells
characteristics.characteristic: cell type
characteristics.text: Healthy control
characteristics.characteristic: disease
characteristics.text: Homo sapiens
characteristics.ontologyTerms: http://purl.obolibrary.org/obo/NCBITaxon_9606
characteristics.characteristic: organism
characteristics.text: Peripheral blood
characteristics.characteristic: source_name
characteristics.text: 48 hours
characteristics.characteristic: time
characteristics.text: Peripheral blood
characteristics.characteristic: tissue
characteristics.text: Healthy control activated naïve B cells 48 hours [HD 3]
characteristics.characteristic: title
characteristics.text: In vitro actvation: anti-Ig+CD40L+IL-25
characteristics.characteristic: treatment